Research Consortium Announces a New Type of Reusable Protective Face Mask for Employers

The Research Consortium announces the creation of a new type of reusable face mask intended to help employers better satisfy OSHA’s general duty requirements.



(San Diego, CA) The Research Consortium is excited to announce the creation of a new type of reusable face mask intended to help employers better satisfy OSHA’s general duty requirements. Not just a physical barrier to slow community spread, this US-made cloth face mask is designed and intended to filter air at very high efficiency levels, inhibit dangerous bio-burden build-up and be worn daily for three months, maintaining its effectiveness. The Stay Safer PRN95+ Protective Face Mask is the unexpected product of research undertaken by RC founder Richard Nicholas who was creating the research institutive when COVID-19 emerged.

Encountering a topic that is broad, complex and clouded with misinformation, he shared his findings in a guide. Covering COVID-19, its transmission, face mask efficacy and related regulatory topics (at 72 pages, with 176 sources) it is aptly entitled The Definitive Employer Guide to Purchasing Face Masks for Your Valued Employees. Not able to find an effective, reusable mask that offered any meaningful degree of wearer protection, Nicholas sought to create one.

While studying viral transmission, Nicholas learned that many viruses (e.g., COVID-19) have a protective outer capsule that assumes negative polarity that can be “neutralized”. Electrocuting pathogenic microbes not only better sanitizes inhaled and exhaled air it inhibits dangerous bio-burden build-up on the mask’s surfaces; reduces wearer self-infection; and mitigates the risk of storing/transporting infected masks; each, a key issue.

This mask employs redundant means by which to short circuit any encapsulated microbes it encounters with a positive charge that’s sustained by two sources. Its cotton inner/outer layers, when paired with the silk-chiffon center layers, create a triboelectric air filter. The fabric is made with an ecofriendly, molecularly-bonded QAC antimicrobial created by Dow Chemical. Both methods are proven to be effective against encapsulated, gram-negative microbes. The mask is engineered for a snug fit, tight seal and high breathability.

The Stay Safer mask is managed/produced by Privy Label, a high-tech, private-label clothing design firm, specializing in curated products for targeted audiences. Owing to its complexity, it is handmade from natural, domestically-sourced materials by a network of ten US manufacturers (ensuring that it can be customized and cost-effectively mass-produced). Nicholas says his “mask is unique as it leverages science and technology to both help curb community spread and offer a meaningful degree of wearer protection.” While he touts the mask’s features, Nicholas emphasizes that no face mask, antimicrobial or fabric can claim to be effective against COVID-19 as no commercial entity has been provided with the virus for testing.

Nicholas, a forty-year healthcare industry veteran, believes that large, value-oriented employers will agree with him that “providing employees with a protective mask can only serve to better satisfy OSHA's requirement to furnish a safe, hazard-free workplace”. He is also courting payors (e.g., health insurers, HMOs, TPA) and health systems to make the mask available to their clients and members. Forecasting sustained market demand, the mask is offered on an optional subscription basis that guarantees quarterly replenishment for $3–4/employee/month.

All face mask royalties will go to support the TPA NETWORK Research Consortium, an emerging industry-wide research initiative to help health plan sponsors evaluate new medical technologies and health innovations by conducting payor-focused translational research and enabling more, smarter and less costly clinical studies. To download the Employer Guide, click here . To learn more about the Stay Safer PRN95+ Protective Face Mask click here. To learn more about the Research Consortium go to www.ResearchConsortium.org


Content Disclaimer: 

The above review statements are those of the sponsor (Source of content) and do not necessarily reflect the official policy, position or views of the content publisher. The content distribution company is therefore not responsible for the content and its authenticity and legal standing of the above subject matter. Each individual is required to exercise its content when making a purchase from the above offer. The information does not constitute advice or an offer to buy. Any purchase made from the above press release is made at your own risk. Editorial merit of this content is subject to news publisher and its downstream partners. Consult an expert advisor/health and professional advisor before any such purchase. Any purchase made from this link is subject to the final terms and conditions of the website's selling as mentioned in the above as source. The content publisher and its downstream distribution partners do not take any responsibility directly or indirectly. If you have any complaints or copyright issues related to this article, kindly contact the company this news is about.  

DISCLAIMER of Liability. IN NO EVENT SHALL OUR PR COMPANY BE LIABLE OR RESPONSIBLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING WITHOUT LIMITATION, LOST PROFITS OR LOST OPPORTUNITIES, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE AND REGARDLESS OF THE CAUSE OF ACTION UPON WHICH ANY SUCH CLAIM IS BASED, INCLUDING, WITHOUT LIMITATION, ANY CLAIM ARISING OUT OF OR IN CONNECTION WITH ANY OF THE CONTENT, INCLUDING, WITHOUT LIMITATION, AUDIO, PHOTOGRAPHS, AND VIDEOS, OR OF THE ACCURACY, RELIABILITY, OR LEGALITY OF ANY STATEMENT MADE IN OR OMITTED FROM ANY advertisement, sponsorship, endorsement, testimonial, opinion, or other product-related or service-related statement or review appearing in the Websites or in ANY post or article distributed via the Websites.





Source: SubmitMyPR
Release ID: 13837